EUVIMEDEUVIMED entdecken
Open Access

Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease

Sara H Bares iD, Xingye Wu, Katherine Tassiopoulos, Jordan E Lake, Susan L Koletar, Robert Kalayjian, Kristine M Erlandson

Clinical Infectious Diseases · 17.02.2024 · 78 (2) · 395-401

DOI: 10.1093/cid/ciad545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 12.09.2023. Verfasst von Sara H Bares und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular Diseases, HIV Infections, Diabetes Mellitus. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Weight gain following initiation of antiretroviral therapy (ART) is common. We assessed the impact of changes in weight in the year following ART initiation with subsequent cardiometabolic disease among AIDS Clinical Trials Group (ACTG) participants.

Methods

Linear regression models were fit to examine the association between change in weight/waist circumference (WC) in weeks 0–48 and change in metabolic parameters in weeks 0–48 and 48–96. Cox proportional hazard models were fit to examine the association between changes in weight/WC in weeks 0–48 and diabetes mellitus (DM), metabolic syndrome, or cardiometabolic and cardiovascular events after week 48.

Results

Participants (N = 2624) were primarily male (81%) and non-White (60%). Mean weight gain from 0–48 weeks was 3.6 kg (SD 7.3); 130 participants developed DM; 360 metabolic syndrome; 424 any cardiometabolic event; 28 any cardiovascular event, over 480 weeks of follow-up. In adjusted models, total cholesterol increased by 0.63 mg/dL (95% confidence interval [CI] [.38, .089]) and LDL by 0.39 mg/dL (0.19, 0.59) per 1 kg increase in weight from weeks 0 to48. Participants who experienced >10% weight gain (vs −5% to 5%) had an increased risk of DM (hazard ratio [HR] 2.01, 95% CI [1.30, 3.08]), metabolic syndrome (HR 2.24, 95% CI [1.55, 2.62]), and cardiometabolic outcomes (HR 1.54, 95% CI [1.22, 1.95]). Participants who lost more than 5% of their baseline weight had a lower risk of incident metabolic syndrome (HR 0.67, 95% CI [0.42, 1.07]). Trends for WC were similar.

Conclusions

Weight and body composition changes in the first year following ART initiation are associated with contemporaneous changes in metabolic parameters and subsequent cardiometabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCardiovascular DiseasesHIV InfectionsDiabetes MellitusHumansMaleWeight GainRisk Factors

Stichwörter der Autor:innen

ART initiationHIVcardiovascular diseasemetabolic diseaseweight gain

Autor:innen und Institutionen

  • Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Department of Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Department of Medicine, The Ohio State University School of Medicine, Columbus, Ohio, USA.
  • MetroHealth, Cleveland, Ohio, USA.

ORCID-Profile: Sara H Bares

Förderung

  • NIAID NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bares, S. H., Wu, X., Tassiopoulos, K., Lake, J. E., Koletar, S. L., Kalayjian, R., & Erlandson, K. M. (2024). Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease. Clinical Infectious Diseases, 78(2), 395-401. https://doi.org/10.1093/cid/ciad545

Vancouver

Bares SH, Wu X, Tassiopoulos K, Lake JE, Koletar SL, Kalayjian R, et al. Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease. Clinical Infectious Diseases. 2024;78(2):395-401. doi:10.1093/cid/ciad545

BibTeX
@article{Bares2024,
  author = {Bares, Sara H and Wu, Xingye and Tassiopoulos, Katherine and Lake, Jordan E and Koletar, Susan L and Kalayjian, Robert and Erlandson, Kristine M},
  title = {Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {2},
  pages = {395--401},
  doi = {10.1093/cid/ciad545}
}
Kostenlos starten →